中医药治疗原发性肝癌的研究进展

宋慧娴; 乔飞; 邵铭

doi:10.3969/j.issn.1001-5256.2016.01.038

中医药治疗原发性肝癌的研究进展

DOI: 10.3969/j.issn.1001-5256.2016.01.038

1. 南京中医药大学第一临床医学院
2. 江苏省中医院感染科

基金项目:

江苏省中医院院级课题(Y13009)；江苏省中管局项目(LZ13042)；

详细信息

中图分类号: R273
计量
- 文章访问数: 2575
- HTML全文浏览量: 71
- PDF下载量: 457
- 被引次数: 0
出版历程
- 收稿日期: 2015-06-23
- 出版日期: 2016-01-20

Research advances in traditional Chinese medicine treatment for primary liver cancer

The First Clinical Medical College of Nanjing University of Chinese Medicine

Research funding:

摘要

摘要: 原发性肝癌是消化系统常见的恶性肿瘤,发现时多处于中晚期,预后差。中医药在防治原发性肝癌方面有其独特的优势,简述了原发性肝癌的病因、病机和中医对肝癌的辩证治疗,总结了中医药联合经肝动脉化疗栓塞术、肝癌根治术、放化疗以及分子靶向药物等综合治疗方面取得的进展,以期对原发性肝癌的临床治疗及改善预后提供一定的参考。
- 肝肿瘤 /
- 中草药 /
- 治疗 /
- 综述
Abstract: Primary liver cancer is a common malignant tumor in the digestive system. Most patients are in the advanced stage when a confirmed diagnosis has been made,and prognosis is often unfavorable. Traditional Chinese medicine( TCM) has unique advantages in the prevention and treatment of primary liver cancer. This article briefly introduces the etiology and pathogenesis of primary liver cancer,as well as syndrome differentiation and treatment of liver cancer with TCM,and summarizes the advances in multimodality therapies including TCM combined with transcatheter arterial chemoembolization,radical surgery for liver cancer,chemoradiotherapy,and molecular- targeted therapy,in order to provide a reference for the clinical treatment and improvement in the prognosis of primary liver cancer.
- liver neoplasms /
- drugs,Chinese herbal /
- therapy /
- review

HTML全文

参考文献(30)

[1]SOERJOMATARAM I,LORTET-TIEULENT J,PARKIN DM,et al.Global burden of cancer in 2008:a systematic analysis of disability-adjusted life-years in 12 world regions[J].Lancet,2012,380(9856):1840-1850.

[2]CHU ZZ,CHEN LH,FENG JH,et al.Advantage and treatment of traditional Chinese medicine in treating primary hepatic carcinoma[J].China J Chin Med,2013,28(10):1446-1448.(in Chinese)储真真,陈立宏,冯久桓,等.中医药治疗原发性肝癌研究进展[J].中医学报,2013,28(10):1446-1448.

[3]WANG L,ZHOU RY.ZHOU Rongyao's experience in treating primary liver cancer with reinforcing kidney and invigorating spleen[J].Liaoning J Tradit Chin Med,2014,41(2):2547-2548.(in Chinese)王磊,周荣耀.周荣耀补肾健健脾法治疗原发性肝癌经验[J].辽宁中医杂志,2014,41(2):2547-2548.

[4]QI YM,WU SS,SHEN MH,et al.General situation of traditional Chinese medicine treatment of primary liver cancer[J].China J Chin Med,2015,30(1):14-16.(in Chinese)戚益铭,吴霜霜,沈敏鹤,等.中医药治疗原发性肝癌研究述评[J].中医学报,2015,30(1):14-16.

[5]CHEN C.Connotation and denotation of doctor Chen Guangrong's therapy of benefi-ting qi and nourishing yin in treating primary hepatocellular carcinoma[J].World J Integr Tradit Western Med,2015,10(2):158-160.(in Chinese)陈超.任光荣治疗原发性肝癌用益气养阴之内涵与外延[J].世界中西医结合杂志,2015,10(2):158-160.

[6]LIU JB,LIU YQ.Update research of primary carcinoma of liver treated by traditional Chinese medicine[J].China J Chin Med,2013,28(1):11-13.(in Chinese)刘俊保,刘延庆.原发性肝癌的中医药治疗研究述评[J].中医学报,2013,28(1):11-13.

[7]XIAO YH.Study on TCM pathogenesis and prevention and treatment of primary hepatic carcinoma[J].Chin J Basic Med Tradit Chin Med,2013,19(6):617-648.(in Chinese)肖跃红.原发性肝癌的中医病机及防治探讨[J].中国中医基础医学杂志,2013,19(6):617-648.

[8]ZHANG T,LIU LM.Reinforcing spleen yin principle treating advanced HCC[J].World Chin Med,2013,8(3):341-344.(in Chinese)张婷,刘鲁明.负阴抱阳,冲气达和——养阴健脾法治疗晚期原发性肝癌[J].世界中医药,2013,8(3):341-344.

[9]ZHOU Y,ZHOU P.To analyze clinical experience of DENG Zhong-jia in curing liver cancer[J].Chin J Exp Med Formul,2012,18(2):260-261.(in Chinese)周滢,周萍.邓中甲教授治疗肝癌经验分析[J].中国实验方剂学杂志,2012,18(2):260-261.

[10]ZHANG YH,QIN X,XU J,et al.On features of TCM syndrome of primary liver carcinoma before and after operation[J].Jiangsu J Traditi Chin Med,2010,42(12):13-14.(in Chinese)张院辉,覃晓,徐静,等.原发性肝癌患者手术前后中医证候特点研究[J].江苏中医药,2010,42(12):13-14.

[11]YE LH,CHENG HB,ZHANG YH,et al.Treatment principle and methods of Chinese medicine for primary liver cancer[J].J Nangjing Univ Tradit Chin Med,2010,26(1):10-13.(in Chinese)叶丽红,程海波,章永红,等.原发性肝癌的中医治则与治法探讨[J].南京中医药大学学报,2010,26(1):10-13.

[12]LI RQ,JIANG YY.Theoretical analysis of primary liver cancer by“temperature method”treatment[J].J Chin Med Pharm,2012,40(3):67-68.(in Chinese)李让钱,江宇泳.原发性肝癌从“温法”论治的理论分析[J].中医药学报,2012,40(3):67-68.

[13]LYU P,SHEN D.Diagnosis and treatment of advanced liver cancer from the perspective of spleen deficiency and phlegm stasis[J].Zhejiang J Tradit Chin Med,2012,47(12):859-860.(in Chinese)吕萍,沈丹.从脾虚夹痰瘀毒论治中晚期肝癌探讨[J].浙江中医杂志,2012,47(12):859-860.

[14]JIANG JK,CHEN RR.“He method”for the treatment of advanced liver cancer[J].Chin Med Modern Distance Educ of China,2013,11(11):83.(in Chinese)姜家康,陈瑞睿.“和法”在中晚期肝癌治疗中的应用[J].中国中医药现代远程教育,2013,11(11):83.

[15]NI J,HUA HQ.Research advances in sorafenib combined with traditional Chinese medicine for the treatment of primary liver cancer[J].Mil Med J Southeast China,2015,17(2):175-177.(in Chinese)倪晶,华海清.索拉非尼联合中药治疗原发性肝癌的研究进展[J].东南国防医药,2015,17(2):175-177.

[16]Ministry of Health of the People's Republic of China.Diagnosis,management,and treatment of hepatocellular carcinoma(V2011)[J].J Clin Hepatol,2011,27(11):1141-1159.(in Chinese)中华人民共和国卫生部.原发性肝癌诊疗规范(2011年版)[J].临床肝胆病杂志,2011,27(11):1141-1159.

[17]GAO ZY,XU XJ,LI WM,et al.Clinical observation of Fuzheng Jiedu Fang combined with transarterial chemoembolization in treating patients with primary hepatic carcinoma[J].Chin J Integr Tradit West Med Liver Dis,2015,25(2):108-109.(in Chinese)高志远,徐湘江,李卫民,等.肝动脉化疗栓塞术联合扶正解毒方治疗原发性肝癌临床回顾性分析[J].中西医结合肝病杂志,2015,25(2):108-109.

[18]LIU GL,SHEN YJ,YOU LJ,et al.Tripterygium wilfordii polyglycoside suppresses inflammatory cytokine expression in rats with diabetic nephropathy[J].Chin J Cell Mol Immunol,2014,30(7):721-724.(in Chinese)刘国玲,沈永杰,尤丽菊,等.雷公藤多苷降低糖尿病肾病大鼠炎性细胞因子的表达[J].细胞与分子免疫学杂志,2014,30(7):721-724.

[19]LIAO NJ,WANG CS.Characteristics of syndrome differentiationbased treatment of primary liver cancer using traditional Chinese medicines combined with transcatheter arterial chemoembolization[J].Jilin J Tradit Chin Med,2013,33(9):889-890.(in Chinese)廖楠君,王常松.中医药联合经导管动脉化疗栓塞术治疗原发性肝癌辨治特点[J].吉林中医药,2013,33(9):889-890.

[20]YAN DQ,BAI XF,LIU QC.Clinical study on modified angelica fritilaria sophorae pill assisting tace to treat primary liver cancer[J].Chin J Inf Tradit Chin Med,2015,22(5):33-36.(in Chinese)闫德祺,白雪峰,刘群才.加味当归贝母苦参丸辅助经肝动脉化疗栓塞术治疗原发性肝癌临床研究[J].中国中医药信息杂志,2015,22(5):33-36.

[21]CHEN H,PAN KG,HE LJ.An overview of research on the antitumor traditional Chinese medicine Actinidia valvata Dunn[J].Strait Pharm J,2011,23(12):9-11.(in Chinese)陈豪,潘坤官,何丽君.抗癌中药猫人参研究概况[J].海峡药学,2011,23(12):9-11.

[22]XU JX,XUE J,QIAN XP,et al.Progress in research on the chemical constituents and anti-tumor effect of Salvia chinensis beth[J].J Mod Oncol,2011,19(3):7-13.(in Chinese)徐敬宣,薛姣,钱晓萍,等.石见穿的化学成分及抗肿瘤作用研究进展[J].现代肿瘤医学,2011,19(3):7-13.

[23]ZHANG HF,XU HX.Chemical components of supercritical CO2extract of Scutellaria barbata and their in vitro antitumor effects[J].Shandong Med J,2010,50(47):47-48.(in Chinese)张海方,许化溪.半枝莲超临界CO2萃取物化学成分分析及其体外抗肿瘤作用[J].山东医药,2010,50(47):47-48.

[24]SUN Z,CUI J,ZHU Y,et al.Traditional Chinese medicine in improving overall survival rates for small hepatocellular carcinoma after resection:a retrospective cohort study[J].J Liaoning Univ Tradit Chin Med,2014,16(12):63-66.(in Chinese)孙振,崔珺,朱役,等.中医药综合方案提高根治术后小肝癌患者生存率回顾性队列研究[J].辽宁中医药大学学报,2014,16(12):63-66.

[25]ZHAI XF,CHEN Z,LI B,et al.Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma:a multicenter randomized controlled trial[J].J Integr Med,2013,11(2):90-100.

[26]ZHANG YJ,HU TC,WANG YQ,et al.Clinical research on traditional Chinese medicine prescription combined with chemotherapy for advanced primary liver cancer[J].Chin Remed Clin,2012,12(4):474-475.(in Chinese)张玉军,胡同春,王玉强,等.中药组方联合化疗治疗中晚期原发性肝癌的临床研究[J].中国药物与临床,2012,12(4):474-475.

[27]WANG RB.Traditional Chinese medicine treatment of liver diseases[J].J Clin Hepatol,2015,31(1):2-6.(in Chinese)王融冰.肝病的中医药治疗[J].临床肝胆病杂志,2015,31(1):2-6.

[28]HE Q.Clinical observation of adjuvant therapy of oxymatrine on hepatitis B virus related primary hepatocellular carcinoma[J].Chin J Hosp Pharm,2014,34(22):1930-1933.(in Chinese)何强.苦参素辅助治疗乙型病毒性肝炎相关原发性肝癌的临床观察[J].中国医院药学杂志,2014,34(22):1930-1933.

[29]CHEN YS,SUN ZW,MENG CC,et al.Molecular pathogenesis and molecular targeted agents for primary liver cancer[J].World Chin J Dig,2015,23(6):914-924.(in Chinese)陈叶盛,孙志为,孟春城,等.原发性肝癌分子生物学机制和相关分子靶向药物的研究进展[J].世界华人消化杂志,2015,23(6):914-924.

[30]SHU J.Research on inhibitory action of herb Hedyotis Diffusae(TCM)extract on human cancer cells and solid tumor in mice[J].Mod J Integr Tradit Chin West Med,2014,23(25):2764-2766.(in Chinese)舒军.中药白花蛇舌草提取物对人体癌细胞及小鼠实体瘤的抑制作用研究[J].现代中西医结合杂志,2014,23(25):2764-2766.

施引文献

资源附件(0)

访问统计